Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study

Hepatology

Volumn 48, Issue 1, 2008, Pages 214-220

  Jepsen, Peter ^a,d   Vilstrup, Hendrik ^a   Andersen, Per Kragh ^b   Lash, Timothy L ^a,c   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Clinical Epidemiology ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH CERTIFICATE; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INFANT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NEWBORN; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RATING SCALE; REGISTER; RISK ASSESSMENT; SURVIVAL; SURVIVAL TIME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 47149103062     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22341     Document Type: Article

References (38)

1. Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008;8:3.
2. Last JM. A dictionary of epidemiology. 4th ed. New York: Oxford University Press; 2001.
3. Sørensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver. A nationwide cohort study in Denmark. J Clin Epidemiol 2003;56:88-93.
4. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003;23:45-53.
5. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445-450.
6. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. HEPATOLOGY 1999;29:664-669.
7. Almdal TP, Sørensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. HEPATOLOGY 1991;13:650-655.
8. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006;7:149-156.
9. Rehm J, Taylor B. Alcohol consumption, stroke and public health - an overlooked relation? Addiction 2006;101:1679-1681.
10. Gutjahr E, Gmel G, Rehm J. Relation between average alcohol consumption and disease: an overview. Eur Addict Res 2001;7:117-127.
11. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. HEPATOLOGY 2006;43:500-505.
12. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231.
13. Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-1520.
14. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001;323:224-228.
15. Hemingway H. Prognosis research: why is Dr. Lydgate still waiting? J Clin Epidemiol 2006;59:1229-1238.
16. Frank L. When an entire country is a cohort. Science 2000;287:2398-2399.
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-268.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
19. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139.
20. Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004;39:858-863.
21. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;21:163-174.
22. Zhang X, Loberiza FR, Klein JP, Zhang MJ. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 2007;88:95-101.
23. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD, et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA 2001;286:1494-1497.
24. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-974.
25. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. 1st ed. Chichester, England: John Wiley & Sons; 1995:331-363.
26. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
27. Rothman KJ. Epidemiology - An Introduction. 1st ed. New York: Oxford University Press; 2002:168-180.
28. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology 1996;7:286-290.
29. Vestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst 1997;21:11-20.
30. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review [in Danish]. Ugeskr Laeger 2001;164:33-37.
31. Rothman KJ. Epidemiology - An Introduction. 1st ed. New York: Oxford University Press; 2002:94-112.
32. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. HEPATOLOGY 2000;31:864-871.
33. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
34. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. HEPATOLOGY 1989;10:1-7.
35. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995;311:222-226.
36. Holman RA, Davis M, Gough KR, Gartell P, Britton DC, Smith RB. Value of a centralised approach in the management of haematemesis and melaena: experience in a district general hospital. Gut 1990;31:504-508.
37. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-321.
38. Bessa X, O'Callaghan E, Balleste B, Nieto M, Seoane A, Panades A, et al. Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding. Dig Liver Dis 2006;38:12-17.